• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Spero Therapeutics, Inc. - Common Stock (NQ:SPRO)

    2.370 +0.080 (+3.49%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 21, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Spero Therapeutics, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 Next >
    12 Health Care Stocks Moving In Tuesday's After-Market Session
     
    Via Benzinga
    Get insights into the top gainers and losers of Tuesday's after-hours session.
    After the closing bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
    Via Chartmill
    SPERO THERAPEUTICS INC (NASDAQ:SPRO) Reports Mixed Q2 2025 Results with Revenue Beat but Stock Decline
    SPERO Therapeutics (SPRO) reported Q2 2025 results with $14.19M revenue, beating estimates, but shares fell 6.8%. Phase 3 trial for tebipenem HBr halted early for efficacy. 
    Via Chartmill
    Earnings Outlook For Spero Therapeutics
     
    Via Benzinga
    An Overview of Spero Therapeutics's Earnings
     
    Via Benzinga
    A Glimpse of Spero Therapeutics's Earnings Potential
     
    Via Benzinga
    The Analyst Verdict: Spero Therapeutics In The Eyes Of 4 Experts
     
    Via Benzinga
    Earnings Scheduled For August 12, 2025
     
    Via Benzinga
    Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
     
    Via Benzinga
    Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May
    Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
     
    Via Benzinga
    Unusual volume stocks in Friday's session
    Discover the stocks with unexpected trading volume in today's session on the US markets. 
    Via Chartmill
    What 4 Analyst Ratings Have To Say About Spero Therapeutics
     
    Via Benzinga
    Spero Therapeutics's Earnings Outlook
     
    Via Benzinga
    The trading volume of these stocks is deviating from the norm in today's session.
    Discover the stocks with unexpected trading volume in today's session on the US markets. 
    Via Chartmill
    12 Health Care Stocks Moving In Wednesday's After-Market Session
     
    Via Benzinga
    These stocks are making the most noise in today's session.
    Stay updated with the latest market activity on Wednesday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight. 
    Via Chartmill
    Small-Cap Movers Under $1: HIT, SPRO, SGN, PRSO, SGBX Drive Momentum Across AI, Biotech, Crypto, Software, Etc.
    Via AB Newswire
    Topics Artificial Intelligence
    12 Health Care Stocks Moving In Wednesday's Intraday Session
     
    Via Benzinga
    Crude Oil Gains 2%; Macy's Lowers Earnings Forecast
    Via Benzinga
    Why Is GSK Partner Spero Therapeutics Stock Skyrocketing On Wednesday?
    GSK and Spero ended a Phase 3 trial early meeting efficacy goals in cUTIs, positioning its treatment as the first oral carbapenem in the U.S. 
    Via Benzinga
    US Stocks Gain; Abercrombie & Fitch Posts Upbeat Earnings
     
    Via Benzinga
    GSK, Spero Therapeutics Stop Antibiotic Trial For Complicated Urinary Tract Infections Early After Positive Results, Retail’s Thrilled
    The early stop follows the trial meeting its primary endpoint of non-inferiority of Tebipenem HBr compared to an intravenous medicine in hospitalised adult patients with cUTI. 
    Via Stocktwits
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
     
    Via Benzinga
    Earnings Scheduled For March 27, 2025
     
    Via Benzinga
    Earnings Scheduled For May 13, 2025
     
    Via Benzinga
    Earnings Scheduled For November 14, 2024
     
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
     
    Via Benzinga
    Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    SPRO Stock Earnings: Spero Therapeutics Beats EPS, Beats Revenue for Q2 2024
    SPRO stock results show that Spero Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    < Previous 1 2 3 4 5 6 7 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.